← Open Payments lookup

CHELSEA ROTHROCK: Open Payments

NPI 1437551769 · LEWISTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,894 in 141 payments from 13 companies in 2025. Trend: 2023 $1,078 · 2024 $1,730 · 2025 $1,894

Food & beverage: $1,894
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.32$447
Neurocrine BioSciences, Inc.18$256
Janssen Pharmaceuticals, Inc15$208
E.R. Squibb & Sons, L.L.C.13$192
Lundbeck LLC15$172
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$171
Axsome Therapeutics, Inc.10$157
ABBVIE INC.15$146
Alkermes, Inc.2$37
Takeda Pharmaceuticals U.S.A., Inc.2$35

Products named: REXULTI, INGREZZA, COBENFY, CAPLYTA, Auvelity, VRAYLAR, ABILIFY ASIMTUFII, SPRAVATO.

Industry payments across PA — which companies pay providers there.